Back

Atrial fibrillation burden: morbidity and mortality.

26 August 2017 (15:40 - 15:50)
Organised by:
Congress Presentation Part of: Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry Atrial fibrillation (AF) Open Access ESC Congress 2017

About the speaker

Photo
Doctor Samuel Z Goldhaber

Brigham and Women's Hospital, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
GARFIELD-AF landmark: first-year outcomes of 52,000 prospective patients.
Professor A. Kakkar (London, GB)
Slides Video
Presentation thumbnail
Heart failure and atrial fibrillation: patient profile and outcomes in the real world.
Doctor A. Turpie (Hamilton, CA)
Slides Video
Presentation thumbnail
Management and outcomes in acute coronary syndromes with atrial fibrillation: where can we improve?
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Chronic kidney disease and atrial fibrillation: geographic differences in routine care.
Professor S. Goto (Isehara, JP)
Slides Video
Presentation thumbnail
Impact of body mass index and the metabolic syndrome on outcomes in atrial fibrillation.
Professor J. Camm (London, GB)
Slides Video

Access the full session

Session thumbnail
Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry

The Event

Event poster

ESC Congress 2017

26 August 2017 15:40 CET
You may be interested in
thumbnail
Congress Session
EHRA honorary lectures
31 March 2025
thumbnail
Congress Presentation
Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry
28 August 2020
thumbnail
Congress Presentation
Atrial fibrillation burden of illness: epidemiology and annual economic impact
23 April 2021
thumbnail
Congress Presentation
Impact of excessive supraventricular ectopic activity detected in the acute phase of stroke or TIA on AF detection and death within 24 months - Results of the prospective MonDAFIS study
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources